Xarelto approved for Secondary prevention in Acute Coronary Syndrome patients in Europe

Advertisements

AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan